1. Multicenter Evaluation of the Idylla GeneFusion in Non-Small-Cell Lung Cancer
- Author
-
Thomas Depoilly, Simon Garinet, Léon C. van Kempen, Ed Schuuring, Sergi Clavé, Beatriz Bellosillo, Cristiana Ercolani, Simonetta Buglioni, Janna Siemanowski, Sabine Merkelbach-Bruse, Verena Tischler, Melanie-Christin Demes, Henry Paridaens, Catherine Sibille, Vincent Thomas de Montpreville, Etienne Rouleau, Artur Bartczak, Monika Pasieka-Lis, Ryan Yee Wei Teo, Khoon Leong Chuah, Marta Barbosa, Carlos Quintana, Michele Biscuola, Mercedes Delgado-Garcia, Davide Vacirca, Alessandra Rappa, Matthew Cashmore, Matthew Smith, Piotr Jasionowicz, Adam Meeney, Patrice Desmeules, Benoit Terris, Audrey Mansuet-Lupo, Targeted Gynaecologic Oncology (TARGON), and Damage and Repair in Cancer Development and Cancer Treatment (DARE)
- Subjects
Lung Neoplasms ,Carcinoma, Non-Small-Cell Lung ,Proto-Oncogene Proteins ,Mutation ,Molecular Medicine ,Humans ,Receptor Protein-Tyrosine Kinases ,Protein-Tyrosine Kinases ,In Situ Hybridization, Fluorescence ,Pathology and Forensic Medicine ,Retrospective Studies - Abstract
Targeted therapy in lung cancer requires the assessment of multiple oncogenic driver alterations, including fusion genes. This retrospective study evaluated the Idylla GeneFusion prototype, an automated and ease-of-use (
- Published
- 2022